MX2017007661A - Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent. - Google Patents

Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent.

Info

Publication number
MX2017007661A
MX2017007661A MX2017007661A MX2017007661A MX2017007661A MX 2017007661 A MX2017007661 A MX 2017007661A MX 2017007661 A MX2017007661 A MX 2017007661A MX 2017007661 A MX2017007661 A MX 2017007661A MX 2017007661 A MX2017007661 A MX 2017007661A
Authority
MX
Mexico
Prior art keywords
plant
submontana
hypoglucemiant
clidemia
agent
Prior art date
Application number
MX2017007661A
Other languages
Spanish (es)
Inventor
Rivas Morales Catalina
Azucena Oranday Cardenas Maria
Angelica De La Garza Ramos Myriam
Leos Rivas Catalina
Mizael Ortiz Martinez David
Original Assignee
Univ Autonoma De Nuevo Leon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Autonoma De Nuevo Leon filed Critical Univ Autonoma De Nuevo Leon
Priority to MX2017007661A priority Critical patent/MX2017007661A/en
Publication of MX2017007661A publication Critical patent/MX2017007661A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention is related to a clidemia submontana plant extract and its use as a hypoglucemiant agent. In the present invention the effect of the extract of this plant on the positive expression of ARNm PPAR? is exposed, accumulation of lipids during adipogenesis, the inhibitory activity of ?-amylase and ?-glucosidase and with moderate toxicity on the VERO line at concentrations higher than the aforementioned biological activity. The present invention belongs to the field of natural products used for the treatment of chronic-degenerative diseases, of importance in public health.
MX2017007661A 2017-06-12 2017-06-12 Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent. MX2017007661A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2017007661A MX2017007661A (en) 2017-06-12 2017-06-12 Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2017007661A MX2017007661A (en) 2017-06-12 2017-06-12 Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent.

Publications (1)

Publication Number Publication Date
MX2017007661A true MX2017007661A (en) 2019-02-08

Family

ID=66212978

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007661A MX2017007661A (en) 2017-06-12 2017-06-12 Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent.

Country Status (1)

Country Link
MX (1) MX2017007661A (en)

Similar Documents

Publication Publication Date Title
PH12017500746B1 (en) Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
BR112017011923A2 (en) bacteria modified to treat diseases associated with hyperammonemia
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
EA201790660A1 (en) KINAZ INHIBITOR
MX2023007212A (en) Epinephrine spray formulations.
ECSP20084373A (en) SUBSTITUTED THIOFENCARBOXAMIDES AND ANALOGUES THEREOF
WO2019040106A3 (en) Compounds, salts thereof and their use in the treatment of diseases
ZA201906100B (en) Combination of a ppar agonist with a fxr agonist
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
MX2017015012A (en) Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne.
PH12017500637A1 (en) Inhibitors of lysine gingipain
NZ726695A (en) Gls1 inhibitors for treating disease
MX2018005628A (en) Treatments of accumulated fat with deoxycholic acid and salts thereof.
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
MX2023012640A (en) Use of riluzole prodrugs to treat ataxias.
MX2015012455A (en) Method for the treatment of fatty liver disease.
WO2019040105A3 (en) Compounds, salts thereof and their use in the treatment of diseases
EA202091653A1 (en) MINOCYCLINE FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES
MX2017007661A (en) Clidemia submontana plant ethanolic extract and its use as a hypoglucemiant agent.
EA201992389A1 (en) SUBSTITUTED N-ARILETHYL-2-AMINOCHINOLIN-4-CARBOXAMIDES AND THEIR APPLICATION
ZA202006986B (en) Dantrolene formulations and methods of their use
FR3016766B1 (en) COMPOSITION COMPRISING SELECTIVE HERBICIDE AND ALGAE EXTRACT, USE OF ALGAE EXTRACT FOR DETOXIFYING PLANTS SUBJECTED TO SELECTIVE HERBICIDE TREATMENT
WO2014059160A3 (en) Plant species that are an effective treatment for viral infections in animals and plants
MY174568A (en) A bioactive composition having natural uv photoprotective properties
EA201991866A1 (en) COMBINED THERAPY

Legal Events

Date Code Title Description
FG Grant or registration